Antibodies against mutated citrullinated vimentin are a better predictor of disease activity at 24 months in early rheumatoid arthritis than antibodies against cyclic citrullinated peptides.

Details

Language :

English

ISSN :

0315162X

Volume :

35

Issue :

6

Database :

Supplemental Index

Journal :

Journal of Rheumatology

Publication Type :

Academic Journal

Accession number :

105707324